|
|
 |
|
Viewing report
|
|
|
|
Global Top 10 Biotechnology Companies — Industry, Financial and SWOT Analysis
Datamonitor, July 2009, Pages: 105
Scope:
‘Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players’ is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.
The report includes the following:
- Industry analysis including market value, market volume, market share and forecast growth till 2012
- Assessment of intensity of competition based on five-forces model including degree of rivalry, substitutes, new entrants, buyer power and supplier power
- SWOT and 5-year financial analysis of top 10 players in the industry
- Descriptive profiles of the leading players including the strategic initiatives undertaken by them in the last 12 months
The top 10 companies have been ascertained based on their global revenues for the financial year 2008.
Highlights:
The global biotechnology market generated total revenues of $171.8 billion in 2007, representing a compound annual growth rate (CAGR) of 10.7% for the period spanning 2003-07. The performance of the market is forecast to decelerate, with an anticipated CAGR of 9.9% for the five-year period 2007-12, which is expected to drive the market to a value of $275.8 billion by the end of 2012.
The top 10 global biotechnology companies recorded revenues of $56.7 billion during 2008, an increase of 12.6% over FY2007. The operating profit of these companies was $15.1 billion in FY2008, an increase of 12.1% over FY2007. The net profit was $10.5 billion during FY2008, an increase of 10.3% over FY2007.
The average operating margin of the top 10 companies was 17% in FY2008 as compared with that of 20.2% in FY2007. The net margin was 10.3% in 2008 as compared with that of 14.9% in 2007.
Since 2003, the global biotechnology market has witnessed a significant growth across different geographies. However, the market growth is expected to decelerate for next few years due to increased number of patent expiries and intensifying competition from biosimilars.
Reasons to Purchase
- Gain insights into the industry, leading companies and competitors through a single report
- Benchmark the leading players using 5-year financial analysis, ratios and adjusted financial statement data
- Form opinions about key players using SWOT Analysis to understand internal factors (strengths and weaknesses) and external factors (opportunities and threats) influencing the companies
- Determine industry attractiveness from five-forces analysis of constituent segments.
Customers who bought this item also bought
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
Top 50 Biotechnology Companies & Their Pipelines 2010
Top 50 Biotechnology Companies & Their Pipelines 2011
Executing Change: Survival Strategies of Big Biotech
Asset Purchase Terms and Agreements in Pharma, Biotech and Diagnostics, 2nd Edition
Drug Delivery Partnering Terms and Agreements in Pharma and Biotech 2nd Edition
Biotechnology - Global Outlook
Co-promotion and Co-marketing Agreements in Pharma, Biotech and Diagnostics, 5th edition
Bioinformatics Partnering Terms and Agreements
Option and Evaluation Agreements in Pharma and Biotech, 2nd Edition
|
|
|
|
